ÂÜÀòÂÒÂ×

Aditya Venugopal has served as Senior Vice President and Head of Corporate Development since August 2022. Aditya has over 15 years of experience in the life science industry – developing strong business partnerships, raising capital, and driving corporate and business development strategy. Most recently,he served as Vice President of Business Development at VectivBio, where he grew the company’s portfolio with the acquisition of a platform technology broadly targeting inborn disorders of metabolism. Before joining VectivBio, he held several roles at Intercept Pharmaceuticals, including Head of Strategic Planning and Diagnostic Strategy. Earlier in Aditya’s career, he spent seven years in strategic life science consulting, first at Easton Associates and subsequently at Navigant Consulting, with a focus on metabolic and autoimmune disorders.

Aditya holds a B.E. in Biotechnology from Anna University in Chennai, India, and a Ph.D. in Immunology and Microbial Pathogenesis from Cornell’s Weill Medical School in New York City.